Home / CHL1 Knockout Cell Lines

CHL1 Knockout Cell Lines

Gene: CHL1

Official Full Name: cell adhesion molecule L1 likeprovided by HGNC

Gene Summary: The protein encoded by this gene is a member of the L1 gene family of neural cell adhesion molecules. It is a neural recognition molecule that may be involved in signal transduction pathways. The deletion of one copy of this gene may be responsible for mental defects in patients with 3p- syndrome. This protein may also play a role in the growth of certain cancers. Alternate splicing results in both coding and non-coding variants. [provided by RefSeq, Nov 2011]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO31567 CHL1 Knockout cell line (HeLa) Human CHL1 1:3~1:6 Negative Online Inquiry

Background

CHL1 Gene Knockout Cell Lines are genetically engineered cell lines in which the CHL1 gene, a critical component associated with neural development and axon guidance, has been intentionally disrupted. These knockout models enable researchers to investigate the functional consequences of CHL1 deficiency on cellular behavior, signaling pathways, and overall physiological processes. By utilizing advanced CRISPR-Cas9 technology or similar gene-editing techniques, these cell lines allow for precise deletions, facilitating the study of gene function in various biological contexts.

The main function of CHL1 Gene Knockout Cell Lines revolves around elucidating the roles of CHL1 in neuronal differentiation, synaptic plasticity, and neurodevelopmental disorders. Researchers can employ these cell lines to perform assays that assess cell proliferation, migration, and apoptosis, providing insights into the pathogenic mechanisms underlying neurodevelopmental conditions. Additionally, these models can aid in drug discovery efforts, particularly in screening compounds that may restore normal cellular functions compromised by CHL1 loss.

The scientific importance of CHL1 Gene Knockout Cell Lines is underscored by their potential applications in both basic research and clinical settings. In the lab, they are instrumental in decoding the genetic and molecular foundations of neural disorders, contributing to the development of targeted therapies. Clinically, insights gleaned from studies using these cell lines could pave the way for novel treatment strategies addressing neurological diseases such as schizophrenia, autism spectrum disorders, and other neuropsychiatric conditions.

What sets CHL1 Gene Knockout Cell Lines apart from traditional models is their specificity and versatility. While other models may exhibit off-target effects or lack the somatic cell context, these engineered cell lines provide a homogenous background, essential for high-throughput screening and reproducibility in experimental outcomes. Their ease of use, coupled with the robustness of gene editing, ensures reliable results, making them a preferred choice among researchers.

For investigators, the unique insights offered by CHL1 Gene Knockout Cell Lines make them invaluable in advancing our understanding of neural biology and related disorders. Our company specializes in developing high-quality biological products, with a strong focus on supporting the scientific community through innovative solutions that enhance research capabilities. With a commitment to excellence and a deep understanding of molecular biology, we strive to empower researchers and clinicians to achieve their objectives efficiently and effectively.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.